Pharmacological and safety aspects of existing requirements and regulations when introducing a new drug.
D000014:Abnormalities, Drug-Induced; D001315:Australia; D002170:Canada; D055598:Chemical Phenomena; D002621:Chemistry; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D005602:France; D006801:Humans; D007194:India; D007558:Italy; D007700:Kinetics; D007880:Legislation, Drug; D008660:Metabolism; D009369:Neoplasms / Q000139:chemically induced; D004364:Pharmaceutical Preparations / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations